Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Earnings release
confidence 98%
filed 2026-08-05
EX-99.1
This is a press release announcing AGI Inc.'s second quarter 2026 financial results, disclosing total revenues of R$3.2 billion (26% YoY growth), net income of R$200.3 million (7% QoQ growth), and key operational metrics including 36% customer growth and expanded market share. The document explicitly states "Agi Inc. Reports Second Quarter 2026 Results" and provides financial highlights typical of an earnings release, making it a discrete earnings event material to investors.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-05
EX-99.1
This exhibit is a formal earnings release for AGI Inc.'s 2026 first half and second quarter results, dated August 5, 2026. It discloses comprehensive financial results including total revenues of R$3,171.0 million in 2Q26, net income of R$200.3 million, and key operational metrics such as active clients reaching 7.6 million. The document explicitly states "earnings release" in its header and contains a detailed letter from the founder, key financial indicators, and performance analysis typical of a quarterly earnings announcement. Material financial results and operational milestones (e.g., market share gains, new product launches, credit rating upgrades) would affect a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-05
EX-99.1
This exhibit is an earnings call presentation for AGI Inc's 2Q26 results, disclosing quarterly financial performance including revenues (R$ 3.2bi, +26% YoY), net income (R$ 200.3mm, +7% QoQ), credit portfolio growth, and key operational metrics. The presentation explicitly states "2Q'26 Results Review of Our Quarterly Financial Performance" and includes detailed financial tables, margins, efficiency ratios, and forward guidance for Q3 and Q4 2026, characteristic of a quarterly earnings release.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-08-05
The 6-K furnishes minutes from Vale's Board of Directors meeting on July 30, 2026, disclosing three governance actions: (1) amendment to the Nomination and Governance Committee's internal regulations; (2) ratification of Wilfred Theodoor Bruijn as Lead Independent Director effective August 1, 2026; and (3) election of Reinaldo Duarte Castanheira Filho as Vice-Chairman of the Board effective August 1, 2026. While these involve leadership appointments and board structure changes, they are routine governance matters that do not constitute a discrete executive appointment or departure event in the traditional sense—rather, they reflect internal board reorganization and committee governance adjustments. The disclosure is material as it affects board composition and governance structure, but does not fit the specific categories of exec_appointment or exec_departure (which typically address C-suite or named executive officer changes).
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-05
Item 2.02
Pacific Biosciences announced Q2 2026 financial results on August 5, 2026, disclosing total revenue of $39.0 million, gross profit of $12.6 million (GAAP), and a net loss of $44.7 million, with full-year 2026 revenue guidance of $155–$165 million.
View raw filing on EDGAR →
8-K
Workforce Reduction
confidence 95%
filed 2026-08-05
Item 2.05
The Board approved a restructuring plan on July 30, 2026, involving a reduction in force of approximately 40 employees (8% of workforce) with estimated pre-tax charges of $2.0 million in Q3 2026 for severance, benefits, and outplacement, and targeted annual operating expense reductions of $30–40 million by end of 2027.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-05
Item 5.02
Mark Van Oene was appointed as President and Chief Executive Officer and Board member effective August 5, 2026, succeeding Christian Henry who stepped down from the CEO role, with a compensation package including a base salary of $743,000, target bonus of 100%, stock options worth $1,687,500, and RSUs worth $562,500.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
This Item 2.02 disclosure reports Novelis Inc.'s financial results for the first quarter of fiscal year 2027 ended June 30, 2026, with a press release attached as Exhibit 99.1. The filing explicitly states "On August 5, 2026, Novelis Inc. issued a press release reporting the company's financial results for its fiscal quarter ended June 30, 2026." Key metrics disclosed include net income of $164 million (up 71% YoY), Adjusted EBITDA of $516 million (up 24% YoY), and net sales of $5.8 billion (up 23% YoY), along with detailed reconciliations of non-GAAP measures and segment information.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-05
Item 2.02
Warner Music Group issued an earnings release on August 5, 2026, announcing financial results for the quarter ended June 30, 2026 (Q3 FY2026), with 10% revenue growth, net income of $200 million, 80% operating income growth to $305 million, and 16% Adjusted OIBDA growth to $433 million.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-05
Item 8.01
The Board of Directors declared a regular quarterly cash dividend of $0.20 per share on both Class A and Class B Common Stock, payable September 1, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
CF Industries issued a press release on August 5, 2026, announcing first half and second quarter 2026 financial results, including net earnings of $1.34 billion for H1 2026 and $727 million for Q2 2026, along with adjusted EBITDA and per-share metrics. This is a standard quarterly earnings disclosure attached as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-05
Item 2.02
Expedia Group released Q2 2026 financial results on August 5, 2026, reporting gross bookings growth of 12%, revenue growth of 14%, net income increase of 166%, and adjusted EBITDA growth of 23% with margin expansion, while raising full-year 2026 guidance.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-05
Item 8.01
Expedia Group's Executive Committee declared a quarterly cash dividend of $0.48 per share of outstanding common stock, payable on September 17, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Xencor announced its financial results for the second quarter ended June 30, 2026 via press release (Exhibit 99.1) on August 5, 2026. The disclosure includes Q2 2026 revenue ($51.2 million), R&D expenses ($71.9 million), G&A expenses ($16.4 million), net loss ($21.7 million or $(0.29) per share), and cash position ($486.4 million), along with financial guidance for year-end 2026 cash resources and runway through 2028. This is a standard quarterly earnings release material to investors assessing the company's financial condition and operational performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-05
Item 2.02
This is a clear earnings release for Q2 2026 filed on August 5, 2026. The Item 2.02 disclosure explicitly states "Fidelity National Financial, Inc. (the 'Company', 'FNF') issued an earnings release announcing its financial results for the Second Quarter of 2026" with the full press release attached as Exhibit 99.1. The release reports net earnings of $288 million ($1.08 per diluted share) and adjusted net earnings of $370 million ($1.39 per share), representing material quarterly financial results that would affect a reasonable investor's assessment of the company.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-05
Item 2.02
Clear Channel Outdoor issued a press release on August 5, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing consolidated revenue of $438.0 million (up 8.7% YoY), income from continuing operations of $(10.0) million, and Adjusted EBITDA of $143.4 million (up 11.6% YoY). The filing includes detailed segment results, cash flow information, and debt position, which are material to investors assessing the registrant's financial performance and condition.
View raw filing on EDGAR →
6-K
Periodic Interim
confidence 98%
filed 2026-08-05
This 6-K furnishes Ternium S.A.'s consolidated condensed interim financial statements as of June 30, 2026 for the six-month period ended June 30, 2026 and 2025. The document explicitly states "This report contains Ternium S.A.'s consolidated financial statements as of June 30, 2026" and includes complete interim income statements, comprehensive income statements, statements of financial position, changes in equity, and cash flows. This is a periodic interim (half-year) financial report, not a discrete event or earnings press release.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Mueller Water Products announced its fiscal 2026 third quarter financial results on August 5, 2026, disclosing net sales of $395.9 million (up 4.1%), net income per diluted share of $0.43, and adjusted net income per diluted share of $0.50, along with raised annual guidance for adjusted EBITDA. The press release attached as Exhibit 99.1 is a standard quarterly earnings announcement with detailed consolidated and segment results, cash flow metrics, and updated fiscal 2026 outlook—a material disclosure affecting investor assessment of the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-05
Item 2.02
Emergent BioSolutions reported Q2 2026 financial results on August 5, 2026, with revenues of $234.3 million (66% YoY increase) and a net loss of $180.2 million driven by a $191.3 million non-cash impairment charge on NARCAN assets, offset by adjusted net income of $30.9 million.
View raw filing on EDGAR →
8-K
Workforce Reduction
confidence 95%
filed 2026-08-05
Item 2.05
The company announced a formal organizational restructuring plan effective August 5, 2026, involving elimination of approximately 93 employee positions and 21 vacant positions, closure of wet laboratories in Gaithersburg, Maryland, with estimated restructuring charges of $10–11.5 million and expected annualized savings of approximately $40 million.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-08-05
Item 5.02
Simon Lowry, Chief Medical Officer and Head of Research and Development, departed the company effective August 19, 2026, as his role was eliminated as part of the organizational restructuring.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-05
Item 2.02
Etsy issued a Shareholder Letter on August 5, 2026 announcing Q2 2026 financial results, disclosing GMS of $2.6B (+7.5% Y/Y Etsy Marketplace), Revenue of $668M (+9.3% Y/Y), Net Income of $114M, and Adjusted EBITDA of $195M with 29.2% margin.
View raw filing on EDGAR →
8-K
Workforce Reduction
confidence 94%
filed 2026-08-05
Item 2.05
Etsy's Audit Committee approved a restructuring plan on August 3, 2026, reducing workforce by approximately 220 employees (12% of headcount) with estimated charges of $35 million in severance, benefits, and related costs, substantially completed by Q3 2026. The restructuring concentrates changes in the Product and Engineering group to flatten teams and accelerate strategic initiatives.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-08-05
Item 8.01
Etsy's Audit Committee authorized a new $2 billion stock repurchase program on August 3, 2026, signaling management confidence in the business and reflecting the company's improved outlook and commitment to long-term shareholder value creation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Owens Corning issued a press release on August 5, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing net sales of $2.8 billion, net earnings margin of 11%, diluted EPS of $3.84, and adjusted EBITDA margin of 24%. This is a standard quarterly earnings release filed under Item 2.02 with the press release attached as Exhibit 99.1, which is the typical format for earnings disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Trupanion issued a press release disclosing Q2 2026 financial results for the quarter ended June 30, 2026, reporting total revenue of $392.9 million (11% YoY increase), net income of $6.8 million ($0.16 per share), adjusted EBITDA of $19.8 million, and operating/free cash flow metrics.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 72%
filed 2026-08-05
Item 8.01
The Board approved an extraordinary dividend of $44 million (approved by New York Department of Financial Services) and authorized a $100 million share repurchase program with no expiration date, representing material capital allocation actions to shareholders.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-05
Item 8.01
The disclosure announces a Board-declared cash dividend on the Company's 7.00% Series A Mandatory Convertible Preferred Stock, with specific per-share amounts ($14.7778 per share, $0.73889 per depositary share), a record date (August 15, 2026), and a payment date (September 1, 2026). This is a straightforward dividend distribution event material to preferred shareholders and the overall capital structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-05
Item 2.02
Barings BDC issued a press release on August 5, 2026 announcing its financial results for the quarter ended June 30, 2026, including net investment income of $29.0 million ($0.28 per share), net realized gains of $18.8 million, and a net increase in net assets from operations of $18.3 million, along with a declared quarterly cash dividend of $0.26 per share.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Archrock issued a press release on August 4, 2026, announcing its second quarter 2026 financial results, including revenue of $371.2 million, net income of $66.7 million, and EPS of $0.38. The filing discloses quarterly earnings with detailed segment performance, balance sheet metrics, and updated full-year 2026 guidance. This is a standard earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
DHI Group disclosed its financial results for the fiscal quarter ended June 30, 2026, via a press release furnished as Exhibit 99.1. The filing reports Q2 2026 revenue of $31.3 million (down 2% YoY), net income of $2.6 million ($0.06 per diluted share), and Adjusted EBITDA of $8.3 million with a 27% margin. The company also reaffirmed full-year revenue guidance and raised Dice margin outlook. This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
American Coastal Insurance Corporation issued a press release disclosing comprehensive financial results for Q2 2026 ended June 30, 2026, including net income of $21.9 million ($0.44 per diluted share), gross premiums written, combined ratios, and book value per share. The company is hosting a quarterly conference call on August 5, 2026 for investors and analysts.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
CDW Corporation disclosed its second quarter 2026 financial results via press release dated August 5, 2026, reporting net sales of $6,572.2M (up 10.0%), net income of $274.4M (up 1.2%), and diluted EPS of $2.15 (up 5.1%), along with segment performance and forward-looking guidance.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-05
Item 8.01
The Board of Directors declared a quarterly cash dividend of $0.630 per common share, payable on September 10, 2026 to stockholders of record as of August 25, 2026.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-08-05
Item 5.02
Albert J. Miralles, Chief Financial Officer and Executive Vice President, announced his intention to retire in 2027 following an orderly transition period. The announcement includes compensatory arrangements for the transition, with Miralles to serve as Executive Advisor at a reduced salary of $60,000 with no incentive awards post-March 2027.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-05
Item 8.01
The Board of Directors announced a quarterly cash dividend on Series A Preferred Stock, with depositary shares receiving $0.421875 per share on September 1, 2026. This is a routine but material dividend declaration affecting preferred shareholders, fitting squarely within the dividend_distribution category.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
The registrant issued a press release on August 5, 2026 announcing financial results for Q2 2026 ended June 30, 2026, disclosing GAAP net loss of $(4) million ($(0.05) per diluted share), earnings available for distribution of $0.46 per share, GAAP book value of $17.75 per share, and an economic return of (0.76)%. The filing explicitly states the press release is furnished as Exhibit 99.1, and the Item 2.02 disclosure is the standard vehicle for quarterly earnings announcements. This is a material quarterly earnings release for a publicly traded REIT.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Energy Recovery issued an earnings press release on August 5, 2026, announcing financial results for Q2 and six months ended June 30, 2026. The disclosure includes detailed financial statements (balance sheet, income statement, cash flows), segment data, and non-GAAP reconciliations. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for earnings releases. The results show material changes: revenue down 57% YoY to $12.0M, net loss of $3.2M vs. profit of $2.1M prior year, and goodwill impairment of $1.7M.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Western Midstream Partners issued a press release on August 5, 2026 announcing second-quarter 2026 financial results, including net income of $394.9 million, record quarterly Adjusted EBITDA of $736.5 million (19% increase year-over-year), and revised full-year 2026 guidance with 10% increases to Adjusted EBITDA and Distributable Cash Flow mid-points. The earnings press release is included as Exhibit 99.1, which is the standard format for earnings disclosures under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
This is a clear earnings release disclosing Zevra's Q2 2026 financial results, including net revenue of $39.7 million (53% increase YoY), net income of $8.8 million, and cash position of $260.2 million. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing includes detailed financial highlights, product performance metrics for MIPLYFFA, and pipeline updates.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Vishay Precision Group issued a press release on August 5, 2026, announcing results for the second quarter of fiscal 2026, with detailed financial metrics including net revenues of $83.9 million (up 11.7%), operating loss of $0.3 million, and diluted net loss per share of $0.13. The disclosure includes segment performance, forward guidance, and a conference call to discuss results, all hallmarks of a quarterly earnings release under Item 2.02.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-05
Item 1.01
Eton Pharmaceuticals entered into a material license agreement on July 31, 2026 to acquire U.S. rights to ASN-001, a late-stage rare disease product candidate from Auson Pharmaceuticals. The transaction involves an upfront payment of $3.0 million, significant milestone payments up to $33.5 million upon FDA approval and sales thresholds, and tiered royalties on future net sales. The acquisition expands Eton's infantile hemangioma franchise and is expected to become the largest revenue-generating product in Eton's portfolio.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
J&J Snack Foods issued a press release on August 5, 2026 reporting financial results for the fiscal third quarter ended June 27, 2026. The disclosure includes detailed quarterly financial statements (consolidated statements of earnings and balance sheets), segment performance data, and management commentary on results. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and operational trends.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Natural Resource Partners L.P. announced its second quarter 2026 financial results via press release on August 5, 2026, disclosing net income of $25.2 million, operating cash flow of $40.9 million, and free cash flow of $41.7 million for the quarter. The filing explicitly states "Natural Resource Partners L.P. announced via press release its earnings and operating results for the second quarter of 2026" and attaches the press release as Exhibit 99.1, which is the standard format for earnings releases under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
This is a clear earnings release disclosing UroGen's Q2 2026 financial results, including total revenue of $72.5 million (up from $24.2 million in Q2 2025), ZUSDURI product revenue of $50.4 million with 73% quarter-over-quarter growth, and a net loss of $14.4 million. The press release is attached as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The results are material to investors as they demonstrate significant commercial traction for the company's lead product.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-05
Item 3.02
The filing discloses an unregistered sale of 256,649.746 shares of common stock at $9.85 per share for an aggregate offering price of $2,528,000, conducted pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D. This is a classic private placement that dilutes existing shareholders and represents a material capital-raising event for the company.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-08-05
Item 3.02
Alternus Clean Energy issued 14,280 shares of Series F Convertible Preferred Stock with a total face value of $14,280,000 to 15 accredited investors pursuant to subscription agreements on August 5, 2026, under Section 4(a)(2) and Regulation D Rule 506(b). The convertible preferred shares are dilutive to existing shareholders and represent a material private placement to raise capital and restructure obligations including debt extension, advisory board appointments, consulting agreements, and interest forgiveness.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-08-05
Item 1.01
The registrant entered into a $525,000 subordinated note agreement with its CEO and chair, Dr. Prasad Jeereddi, creating a direct financial obligation due July 31, 2027 at 10% interest with a 2% prepayment penalty. While the transaction also includes warrants (which could suggest a dilutive issuance), the Item 1.01 caption and the prose center on the debt instrument itself as the material agreement. The subordinated nature, insider lending, and potential for up to $1.5 million aggregate investment make this a material debt issuance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Zevia PBC issued an earnings release on August 5, 2026, announcing financial results for the second quarter ended June 30, 2026. The disclosure includes detailed quarterly financial statements (consolidated statements of operations, balance sheets, and cash flows), net sales of $45.0 million, net loss of $2.9 million, and forward guidance for full-year 2026 and Q3 2026. This is a standard quarterly earnings release furnished under Item 2.02, with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
American Superconductor Corporation announced its financial results for the first quarter ended June 30, 2026, reporting revenues of $94.1 million (30% YoY growth) and net income of $9.5 million ($0.21 per share), with forward guidance provided for Q2.
View raw filing on EDGAR →